VB

Vishalbhai Bharatbhai Dadhaniya

Active Director Designated Partner DIN 10530564
DIN 10530564 First appointment Mar 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Vishalbhai Bharatbhai Dadhaniya

Data last updated:

Vishalbhai Bharatbhai Dadhaniya is a Designated Partner at Jvioush Lifesciences Llp (since 2024). The company operates in Pharma.

DIN 10530564
Primary Designation Designated Partner
Industry Pharma
First Appointment 01 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 Mar 20242024Active

Board colleagues of Vishalbhai Bharatbhai Dadhaniya

NameDINCompanyDesignation
Femin Narendrbhai Solanki10530565Jvioush Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Jvioush Lifesciences Llp
Premium access

Shareholding and investment profile for Vishalbhai Bharatbhai Dadhaniya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishalbhai Bharatbhai Dadhaniya

Vishalbhai Bharatbhai Dadhaniya currently holds 1 directorship: Jvioush Lifesciences Llp (Designated Partner, since 01 Mar 2024).

Vishalbhai Bharatbhai Dadhaniya was first appointed on 01 Mar 2024 as Designated Partner at Jvioush Lifesciences Llp.

The current boards of Vishalbhai Bharatbhai Dadhaniya's companies include Femin Narendrbhai Solanki (Jvioush Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available